Individuals with type 2 diabetes display increased hepatic synthesis of VLDL particles, resulting in elevated VLDL-triacylglycerol [4, 40], presumably due to the impaired ability of insulin to suppress VLDL synthesis. The gene discussed is INS; the disease is type 2 diabetes mellitus.